HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laurence H Patterson Selected Research

ICT 2552

1/2016The use of thermographic imaging to evaluate therapeutic response in human tumour xenograft models.
9/2010Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laurence H Patterson Research Topics

Disease

29Neoplasms (Cancer)
05/2021 - 08/2002
5Hypoxia (Hypoxemia)
05/2022 - 08/2002
5Neoplasm Metastasis (Metastasis)
07/2020 - 10/2012
3Prostatic Neoplasms (Prostate Cancer)
11/2017 - 10/2012
3Ovarian Neoplasms (Ovarian Cancer)
10/2005 - 07/2003
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 05/2017
2Breast Neoplasms (Breast Cancer)
01/2017 - 11/2011
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2013 - 01/2013
1Bradycardia
01/2022
1Squamous Cell Carcinoma of Head and Neck
05/2017
1Lung Neoplasms (Lung Cancer)
01/2016
1Thrombosis (Thrombus)
08/2014
1Osteoporosis
08/2014
1Colonic Neoplasms (Colon Cancer)
06/2013
1Transitional Cell Carcinoma
01/2013
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2013
1Neuroblastoma
01/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2013
1Adenocarcinoma
10/2012
1Disease Progression
11/2011
1Necrosis
09/2010
1Osteosarcoma (Osteogenic Sarcoma)
10/2005
1Turcot syndrome
01/2005

Drug/Important Bio-Agent (IBA)

8Pharmaceutical PreparationsIBA
05/2021 - 09/2004
7ProdrugsIBA
05/2022 - 01/2010
5polysialic acidIBA
05/2021 - 01/2013
4DuocarmycinsIBA
01/2021 - 01/2013
4Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2021 - 01/2013
4DNA (Deoxyribonucleic Acid)IBA
06/2012 - 01/2005
3OCT1002IBA
05/2022 - 04/2017
3AQ4NIBA
05/2022 - 08/2002
3EnzymesIBA
01/2021 - 06/2013
3IntegrinsIBA
05/2017 - 10/2012
3Cytotoxins (Cytolysins)IBA
01/2016 - 01/2013
3Cisplatin (Platino)FDA LinkGeneric
10/2005 - 07/2003
2Protein Isoforms (Isoforms)IBA
01/2021 - 08/2002
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016 - 09/2010
2ICT 2552IBA
01/2016 - 09/2010
2ICT2588IBA
04/2014 - 09/2010
2Cytochrome P-450 CYP1A1 (CYP1A1)IBA
08/2013 - 01/2013
2Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
07/2013 - 01/2013
2ChemokinesIBA
01/2013 - 11/2011
2AlchemixIBA
06/2012 - 07/2003
2OxidesIBA
11/2006 - 08/2002
2AnthraquinonesIBA
10/2005 - 07/2003
1Type I DNA Topoisomerases (Topoisomerase I)IBA
05/2022
1Lidocaine (Xylocaine)FDA LinkGeneric
01/2022
1Polysaccharides (Glycans)IBA
05/2021
1endo-alpha-sialidaseIBA
05/2021
1N-Acetylneuraminic Acid (Sialic Acid)IBA
05/2021
1CarcinogensIBA
01/2021
1hydroxide ionIBA
01/2021
1Paclitaxel (Taxol)FDA LinkGeneric
10/2019
1CyclodextrinsIBA
10/2019
11- cyclohexyl- 2- (5H- imidazo(5,1- a)isoindol- 5- yl)ethanolIBA
10/2019
1Docetaxel (Taxotere)FDA Link
11/2017
1abirateroneIBA
11/2017
1cabazitaxelFDA Link
11/2017
1Arginine (L-Arginine)FDA Link
05/2017
1Glycine (Aminoacetic Acid)FDA LinkGeneric
05/2017
1Aspartic Acid (Aspartate)FDA Link
05/2017
1bicalutamide (Casodex)FDA LinkGeneric
04/2017
1Milk Proteins (Milk Protein)IBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1PolymersIBA
10/2016
1GlycosyltransferasesIBA
10/2016
1CarbohydratesIBA
10/2016
1Indicators and Reagents (Reagents)IBA
04/2014
1Peptides (Polypeptides)IBA
04/2014
1von Willebrand FactorIBA
04/2014
1cyclopropapyrroloindoleIBA
08/2013
1(1- (chloromethyl)- 1,2- dihydropyrrolo(3,2- e)indol- 3(6H)- yl)(5- fluoro- 1H- indol- 2- yl)methanoneIBA
06/2013
1Histones (Histone)IBA
06/2013
1Mixed Function Oxygenases (Monooxygenases)IBA
06/2013
1(5- chloro- 1H- indol- 2- yl)(1- (chloromethyl)- 1,2- dihydropyrrolo(3,2- e)indol- 3(6H)- yl)methanoneIBA
06/2013
1Chemokine ReceptorsIBA
01/2013
1(1- (chloromethyl)- 1,2- dihydropyrrolo(3,2- e)indol- 3(6H)- yl)(5- methoxy- 1H- indol- 2- yl)methanoneIBA
01/2013
1Chemokine CXCL12IBA
01/2013
1Antineoplastic Agents (Antineoplastics)IBA
11/2011
1Membrane-Associated Matrix MetalloproteinasesIBA
09/2010
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
09/2010
1Oxygen (Dioxygen)IBA
09/2010
1Hormones (Hormone)IBA
01/2010
1Adenosine Triphosphate (ATP)IBA
01/2007
1A-Form DNA (A-DNA)IBA
10/2005
1Topoisomerase II InhibitorsIBA
10/2005
1Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2005
1Alkylating AgentsIBA
01/2005
1AntimetabolitesIBA
01/2005
1CamptothecinIBA
01/2005
1Biological ProductsIBA
03/2004
1AnthracyclinesIBA
07/2003
1Complementary DNA (cDNA)IBA
01/2003
1Cytochrome P-450 CYP3AIBA
01/2003

Therapy/Procedure

4Therapeutics
01/2021 - 10/2012
4Drug Therapy (Chemotherapy)
06/2013 - 08/2002
1Immunotherapy
10/2019